Cargando…
Viral vector and nucleic acid vaccines against COVID-19: A narrative review
After about 2 years since the first detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Wuhan, China, in December 2019 that resulted in a worldwide pandemic, 6.2 million deaths have been recorded. As a result, there is an urgent need for the development of a safe...
Autores principales: | Khoshnood, Saeed, Ghanavati, Roya, Shirani, Maryam, Ghahramanpour, Hossein, Sholeh, Mohammad, Shariati, Aref, Sadeghifard, Nourkhoda, Heidary, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470835/ https://www.ncbi.nlm.nih.gov/pubmed/36118203 http://dx.doi.org/10.3389/fmicb.2022.984536 |
Ejemplares similares
-
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
por: Heidary, Mohsen, et al.
Publicado: (2022) -
An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines
por: Khoshnood, Saeed, et al.
Publicado: (2022) -
Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022) -
The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023) -
Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
por: Khoshnood, Saeed, et al.
Publicado: (2021)